UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 265

Sortiert nach

Robert B. Sim-Tribute

Viruses, 2021-08, Vol.13 (9), p.1681

Erdei, Anna

2021

Volltextzugriff (PDF)

The push-pull intercrop Desmodium does not repel, but intercepts and kills pests

eLife, 2024-03, Vol.13

2024

Volltextzugriff (PDF)

The role of CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in complement-mediated phagocytosis and podosome formation by human phagocytes

Immunology letters, 2017-09, Vol.189, p.64-72

2017

Volltextzugriff (PDF)

Non-identical twins: Different faces of CR3 and CR4 in myeloid and lymphoid cells of mice and men

Seminars in cell & developmental biology, 2019-01, Vol.85, p.110-121

2019

Volltextzugriff (PDF)

The differential role of CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in the adherence, migration and podosome formation of human macrophages and dendritic cells under inflammatory conditions

PloS one, 2020-05, Vol.15 (5), p.e0232432-e0232432

2020

Volltextzugriff (PDF)

CD11c/CD18 Dominates Adhesion of Human Monocytes, Macrophages and Dendritic Cells over CD11b/CD18

PloS one, 2016-09, Vol.11 (9), p.e0163120-e0163120

2016

Volltextzugriff (PDF)

Biochemical and pharmacological investigation of novel nociceptin/OFQ analogues and N/OFQ-RYYRIK hybrid peptides

Peptides (New York, N.Y. : 1980), 2019-02, Vol.112, p.106-113

2019

Volltextzugriff (PDF)

Revisiting the Coreceptor Function of Complement Receptor Type 2 (CR2, CD21); Coengagement With the B-Cell Receptor Inhibits the Activation, Proliferation, and Antibody Production of Human B Cells

Frontiers in immunology, 2021-04, Vol.12, p.620427-620427

2021

Volltextzugriff (PDF)

BCR activated CLL B cells use both CR3 (CD11b/CD18) and CR4 (CD11c/CD18) for adhesion while CR4 has a dominant role in migration towards SDF-1

PloS one, 2021-07, Vol.16 (7), p.e0254853-e0254853

2021

Volltextzugriff (PDF)

Activated Human Memory B Lymphocytes Use CR4 (CD11c/CD18) for Adhesion, Migration, and Proliferation

Frontiers in immunology, 2020-09, Vol.11, p.565458-565458

2020

Volltextzugriff (PDF)

Complement Receptor Type 1 (CR1, CD35), the Inhibitor of BCR-Mediated Human B Cell Activation, Differentially Regulates TLR7, and TLR9 Induced Responses

Frontiers in immunology, 2019-07, Vol.10, p.1493-1493

2019

Volltextzugriff (PDF)

Autoantibodies Against the Complement Regulator Factor H in the Serum of Patients With Neuromyelitis Optica Spectrum Disorder

Frontiers in immunology, 2021-04, Vol.12, p.660382-660382

2021

Volltextzugriff (PDF)

Erdei Anna zárszava a Bolyai János Kutatási Ösztöndíjak átadásán • Closing Remarks by Anna Erdei at the Presentation of the Bolyai János Research Scholarships

Magyar tudomány, 2023-12

Erdei, Anna

2023

Volltextzugriff (PDF)

In-situ and label-free optical monitoring of the adhesion and spreading of primary monocytes isolated from human blood: Dependence on serum concentration levels

Biosensors & bioelectronics, 2014-04, Vol.54, p.339-344

2014

Volltextzugriff (PDF)

Single cell adhesion assay using computer controlled micropipette

PloS one, 2014-10, Vol.9 (10), p.e111450-e111450

2014

Volltextzugriff (PDF)

Insect chemical ecology: chemically mediated interactions and novel applications in agriculture

Arthropod-plant interactions, 2020, Vol.14 (6), p.671-684

2020

Volltextzugriff (PDF)

Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients

International immunology, 2013-01, Vol.25 (1), p.25-33

2013

Volltextzugriff (PDF)

Biochemical and pharmacological characterization of three opioid-nociceptin hybrid peptide ligands reveals substantially differing modes of their actions

Peptides (New York, N.Y. : 1980), 2018-01, Vol.99, p.205-216

2018

Volltextzugriff (PDF)

New opioid receptor antagonist: Naltrexone-14-O-sulfate synthesis and pharmacology

European journal of pharmacology, 2017-08, Vol.809, p.111-121

2017

Volltextzugriff (PDF)

Design, synthesis and biological profile of mixed opioid agonist/N-VGCC blocker peptides

New journal of chemistry, 2018, Vol.42 (8), p.5656-5659

2018

Volltextzugriff (PDF)

Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors

Journal of enzyme inhibition and medicinal chemistry, 2017-01, Vol.32 (1), p.444-451

2017

Volltextzugriff (PDF)

Automated single cell sorting and deposition in submicroliter drops

Applied physics letters, 2014-08, Vol.105 (8)

2014

Volltextzugriff (PDF)

Cyclic Biphalin Analogues Incorporating a Xylene Bridge: Synthesis, Characterization, and Biological Profile

ACS medicinal chemistry letters, 2017-08, Vol.8 (8), p.858-863

2017

Volltextzugriff (PDF)

Complement Receptor Type 1 Suppresses Human B Cell Functions in SLE Patients

Journal of Immunology Research, 2016-01, Vol.2016, p.5758192-10

2016

Volltextzugriff (PDF)

Opioid Receptor Activity and Analgesic Potency of DPDPE Peptide Analogues Containing a Xylene Bridge

ACS medicinal chemistry letters, 2017-04, Vol.8 (4), p.449-454

2017

Volltextzugriff (PDF)

1 – 25 von 265

Suche als RSS-Feed

Aktive Filter

PublikationsformBuchkapitel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(254)
Mit Volltextzugriff
(252)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(173)
Life Sciences & Biomedicine
(163)
Humans
(95)
Immunology
(92)
Animals
(82)
Mice
(57)
Biochemistry & Molecular Biology
(37)
Female
(33)
Biological And Medical Sciences
(29)
Male
(27)
Allergy And Immunology
(26)
B-Lymphocytes - Immunology
(25)
Fundamental And Applied Biological Sciences. Psychology
(24)
Complement
(21)
Cells, Cultured
(20)
Pharmacology & Pharmacy
(19)
Mice, Inbred Balb C
(18)
Fundamental Immunology
(17)
Complement C3 - Immunology
(16)
Rats
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Robert B. Sim-Tribute

The push-pull intercrop Desmodium does not repel, but intercepts and kills pests

The role of CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in complement-mediated phagocytosis and podosome formation by human phagocytes

Non-identical twins: Different faces of CR3 and CR4 in myeloid and lymphoid cells of mice and men

The differential role of CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in the adherence, migration and podosome formation of human macrophages and dendritic cells under inflammatory conditions

CD11c/CD18 Dominates Adhesion of Human Monocytes, Macrophages and Dendritic Cells over CD11b/CD18

Biochemical and pharmacological investigation of novel nociceptin/OFQ analogues and N/OFQ-RYYRIK hybrid peptides

Revisiting the Coreceptor Function of Complement Receptor Type 2 (CR2, CD21); Coengagement With the B-Cell Receptor Inhibits the Activation, Proliferation, and Antibody Production of Human B Cells

BCR activated CLL B cells use both CR3 (CD11b/CD18) and CR4 (CD11c/CD18) for adhesion while CR4 has a dominant role in migration towards SDF-1

Activated Human Memory B Lymphocytes Use CR4 (CD11c/CD18) for Adhesion, Migration, and Proliferation

Complement Receptor Type 1 (CR1, CD35), the Inhibitor of BCR-Mediated Human B Cell Activation, Differentially Regulates TLR7, and TLR9 Induced Responses

Autoantibodies Against the Complement Regulator Factor H in the Serum of Patients With Neuromyelitis Optica Spectrum Disorder

Erdei Anna zárszava a Bolyai János Kutatási Ösztöndíjak átadásán • Closing Remarks by Anna Erdei at the Presentation of the Bolyai János Research Scholarships

In-situ and label-free optical monitoring of the adhesion and spreading of primary monocytes isolated from human blood: Dependence on serum concentration levels

Single cell adhesion assay using computer controlled micropipette

Insect chemical ecology: chemically mediated interactions and novel applications in agriculture

Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients

Biochemical and pharmacological characterization of three opioid-nociceptin hybrid peptide ligands reveals substantially differing modes of their actions

New opioid receptor antagonist: Naltrexone-14-O-sulfate synthesis and pharmacology

Design, synthesis and biological profile of mixed opioid agonist/N-VGCC blocker peptides

Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors

Automated single cell sorting and deposition in submicroliter drops

Cyclic Biphalin Analogues Incorporating a Xylene Bridge: Synthesis, Characterization, and Biological Profile

Complement Receptor Type 1 Suppresses Human B Cell Functions in SLE Patients

Opioid Receptor Activity and Analgesic Potency of DPDPE Peptide Analogues Containing a Xylene Bridge

Aktive Filter

Suchergebnisse filtern